Tevogen
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15 Independence Blvd Ste 410, Warren, Ne...Phone Number
(877) 838-6436Website
www.tevogen.comRevenue
-Stock Symbol
TVGNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Tevogen
Tevogen Bio is a clinical-stage biotechnology company focused on developing precision T-cell immunotherapies for infectious diseases, cancers, and other medical conditions. The company leverages its proprietary ExacTcell™ technology platform to develop off-the-shelf, personalized cell therapies and uses AI-driven research initiatives to accelerate target identification and drug development. Tevogen aims to improve access to advanced immunotherapies through scalable and cost-effective biotechnology solutions.Explore more
Tevogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tevogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Tevogen
Check out if Tevogen is spiking on competitors!
Earning: See what the market has to say on Tevogen recently announced quarterly report
Product Launch: Get notified when Tevogen launches new products
Check if Tevogen has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tevogen has new funding data
Click to see if Tevogen had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Tevogen, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Tevogen
Compare insights from companies similar to Tevogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tevogen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tevogen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tevogen.
Tevogen financials insights
Gather financial insights about Tevogen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$50M
Tevogen Tech Stack
A closer look at the technologies used by Tevogen
Most Recent Scoops
Project
Tevogen has made progress at its R&D laboratory in Doylestown, Pennsylvania in sensitizing naive T cells, an advancement that reduces the company's dependence on donors with pre-existing immunity.
Research & Development, Laboratory Operations
Project
Tevogen has stated that it does not intend to initiate a new clinical trial until a clinical manufacturing plant is established in the United States, characterizing this as a technical capability requirement rather than a funding constraint.
Funding, Clinical Operations, Finance
Earnings
reported a net loss from operations for the fiscal year ended December 31, 2025, that was reduced by more than 50% compared to the prior fiscal year, while the company maintained and increased its operational capabilities.
Earnings, Finance, Financial Operations
Project
Tevogen has completed a successful proof-of-concept trial and published a dose-finding study, providing initial proof of concept and dose finding for the first clinical product of the company's patented ExacTcell cell therapy platform.
Proof of Concept (POC), Medical Research, Pharmaceuticals, Clinical Operations
Project
Product Development, Medical Research, Clinical Operations, Manufacturing Operations
Tevogen News & Media
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
WARREN, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced that its 2026 Annual Meeting of Stockholders (the “Annual Meeting)” is scheduled for Monday, August 24, 2026.Tevogen Announces Formation of a Healthcare Services Initiative
Tevogen launches Healthcare Services initiative to evaluate MSO and CRO acquisitions with potential to support approximately $100M in annual revenue.Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
Tevogen advances strategic acquisition initiatives that, if consummated, could support financial self-sufficiency and ~$100M in annual revenue.Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
Tevogen evaluates MSO acquisition as part of strategy to build revenue-generating healthcare enterprise across biotech, AI, and services.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tevogen
Sign Up For FreeTo access detailed company insights
Tevogen Bio is a clinical-stage biotechnology company focused on developing precision T-cell immunotherapies for infectious diseases, cancers, and other medical conditions. The company leverages its proprietary ExacTcell™ technology platform to develop off-the-shelf, personalized cell therapies and uses AI-driven research initiatives to accelerate... Read More
